ArticleEuropean journal of pediatrics2025
Performance of the pediatric index of mortality (PIM-3) in a Moroccan PICU: challenges in resource-limited settings.
Article in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prognostic scores such as the Pediatric Index of Mortality (PIM-3) are widely used to estimate mortality risk in PICUs, yet their performance in low- and middle-income countries (LMICs) remains uncertain. We aimed to evaluate the predictive performance of PIM-3 in a Moroccan PICU; associations with ICU length of stay (LOS) and duration of mechanical ventilation (MV) were secondary exploratory outcomes. We conducted a prospective cohort study in the Mother-Child PICU at Hassan II University Hospital (Fez, Morocco) from June 1 to September 30, 2024, including all children aged 1 month to 16 years. PIM-3 variables were collected at admission. The primary focus was model performance: discrimination (AUROC, AUPRC), calibration (Hosmer-Lemeshow), and standardized mortality ratio (SMR). Univariable and multivariable regressions were used for the secondary exploratory analyses (mortality correlates, LOS, and MV duration). Among 122 patients, observed mortality was 28.7%, exceeding PIM-3 predictions (SMR = 7.7; p < 0.001). PIM-3 showed good discrimination (AUROC = 0.86; AUPRC = 0.65) but poor calibration. In secondary exploratory analyses, higher PIM-3 scores, lower GCS, multiple organ failures, and need for MV were associated with mortality. MV increased ICU stay duration and organ failures prolonged ventilation duration.
conclusionIn this Moroccan PICU, PIM-3 showed good discrimination but poor calibration and thus underestimated mortality. These findings support considering local recalibration in future work, and exploration of machine-learning-based adaptation for LMIC settings. Clinical trial number: Not applicable. WHAT IS KNOWN: • PIM-3 is widely used to estimate PICU mortality risk. It was developed and calibrated largely in high-resource settings. • External validations often show good discrimination but variable calibration, with under- or over-estimation in LMICs due to differences in case-mix, care processes, and resources. WHAT IS NEW: • In a prospective Moroccan PICU cohort (n=122), PIM-3 showed good discrimination (AUROC 0.86; AUPRC 0.65) but markedly underestimated mortality (SMR 7.7). • Higher PIM-3 risk, lower Glasgow Coma Scale, multiple organ failures, and mechanical ventilation were associated with death, underscoring the need for local recalibration and exploration of machine learning-based adaptations for LMICs.
Indexed as
Identifiers
41240119What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.